Trials Currently Enrolling at Associated Neurologists

Mild Cognitive Impairment (MCI) | Multiple SclerosisNeurogenic Orthostatic Hypotension

Mild Cognitive Impairment (MCI)

Protocol Title"Long-Term Nicotine Treatment of Mild Cognitive Impairment"
Trial PhasePhase II
Principal Investigator (PI)Samuel Markind, MD
Protocol NumberNIC (ATRI-002)
ClinicalTrials.gov Identifier:NCT02720445
For further information on this trial from ClinicalTrials.govClick here.

Return to Top

Multiple Sclerosis

Protocol Title"Multicenter, randomized, double-blind, parallel-group, add-on, superiority study to compare the efficacy and safety of ponesimod to placebo in subjects with active relapsing multiple sclerosis who are treated with dimethyl fumarate (Tecfidera®) (POINT Study)"
Trial PhasePhase III
Principal Investigator (PI)David Greco, MD
Protocol NumberAC-058B302
ClinicalTrials.gov Link:Click here.
ClinicalTrial.gov Identifier:NCT02907177

Return to Top

Neurogenic Orthostatic Hypotension

Protocol Title"RESTORE: A clinical study of patients with symptomatic neurogenic orthostatic hypotension to assess sustained effects of Droxidopa therapy"
Trial PhasePhase IV
Principal Investigator (PI)Behzad Habibi, MD
Protocol Number16306A
ClinicalTrials.gov Identifier:NCT02586623
For further information on this trial from ClinicalTrials.govClick here.

Return to Top

If you would like to learn more about any of the trials above, please contact our Clinical Research Department at (203) 748-2551, extension 351 for further information.